Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune System Disorder (Healthy Volunteer)”

1,013 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,013 results

Not applicableStudy completedNCT02504840
What this trial is testing

Natural History of Multiple Sclerosis and Its Mimickers

Who this might be right for
Neurologic DisordersHealthy VolunteersMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 104
Early research (Phase 1)Study completedNCT05918588
What this trial is testing

Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects

Who this might be right for
Immune System Disorder (Healthy Volunteer)
Kadmon, a Sanofi Company 32
Early research (Phase 1)UnknownNCT02423538
What this trial is testing

First-in-Human Single Ascending Dose of SHR0302

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 64
Early research (Phase 1)Looking for participantsNCT07205081
What this trial is testing

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 72
Early research (Phase 1)Ended earlyNCT01934101
What this trial is testing

Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 64
Not applicableStudy completedNCT02392481
What this trial is testing

Asthma Biomarker Study

Who this might be right for
Asthma
Boehringer Ingelheim 69
Early research (Phase 1)Ended earlyNCT06119529
What this trial is testing

LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Who this might be right for
HealthyAtopic Dermatitis
Eli Lilly and Company 18
Early research (Phase 1)Study completedNCT00782600
What this trial is testing

Study of Controlled Release Formulations of CE-224,535 Against the Immediate Release Formulation in Normal Volunteers

Who this might be right for
Rheumatoid Arthritis
Pfizer 16
Early research (Phase 1)Study completedNCT00365339
What this trial is testing

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir

Who this might be right for
HIV Infections
Bristol-Myers Squibb 40
Early research (Phase 1)Study completedNCT00851383
What this trial is testing

A Trial to Evaluate Ad35-GRIN/ENV HIV Vaccine in Healthy Adult Volunteers

Who this might be right for
HIVHIV Infections
International AIDS Vaccine Initiative 56
Early research (Phase 1)Study completedNCT01138072
What this trial is testing

A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 14
Early research (Phase 1)Study completedNCT01381445
What this trial is testing

A Study Assessing GW870086's Potential to Cause Skin Thinning

Who this might be right for
Dermatitis, Atopic
GlaxoSmithKline 20
Post-approval studies (Phase 4)Study completedNCT00913666
What this trial is testing

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Who this might be right for
Multiple Sclerosis
Biogen 121
Early research (Phase 1)Looking for participantsNCT07200596
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA)
Guangdong Hengrui Pharmaceutical Co., Ltd 16
Early research (Phase 1)Study completedNCT02085473
What this trial is testing

Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers

Who this might be right for
AsthmaHealthy Subjects or Volunteers
MedImmune LLC 60
Early research (Phase 1)Study completedNCT04819854
What this trial is testing

Single and Multiple Ascending Dose Study With EP395

Who this might be right for
Adult ALL
EpiEndo Pharmaceuticals 78
Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Not applicableUnknownNCT00172666
What this trial is testing

Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)

Who this might be right for
Rheumatoid ArthritisSystemic Lupus Erythematosus
National Taiwan University Hospital 450
Early research (Phase 1)Study completedNCT00517543
What this trial is testing

Examine the Effect of Particle Size on Bioequivalence and Bioavailability

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Rheumatoid ArthritisAtherosclerosis
GlaxoSmithKline 36
Early research (Phase 1)Study completedNCT01610310
What this trial is testing

Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

Who this might be right for
HealthyMultiple Sclerosis
Biogen 55
Load More Results